Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Lumos Pharma Inc.
DescriptionSmall molecule creatine mimetic
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationCreatine transporter deficiency (CTD)
Indication DetailsTreat creatine transporter deficiency (CTD)
Regulatory Designation U.S. - Orphan Drug (Treat creatine transporter deficiency (CTD))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today